Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors: a Single Arm Trial.

NCT06836492 is registered in ClinicalTrials.gov with Yizhuo Zhang as lead sponsor.

NCT NCT06836492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06836492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors: a Single Arm Trial.
Lead sponsor
Yizhuo Zhang
Phase
Phase 3
Overall status
Recruiting
Start date
January 30, 2017
Completion date
December 31, 2029
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric cancer, rhabdomyosarcoma